The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Conclusion] Our data suggest that the ALC is one of the predictive factors for R/R and OS in patients with regressive MTX-LPDs.DisclosuresTokuhira: Mitsubishi Tanabe Pharma Corporation: Speakers Bureau; AYUMI Pharmaceutical Corporation: Speakers Bureau; Bristol-Myers Squibb: Speakers Bureau; Chugai: Speakers Bureau. Tamaru: Nichirei Bioscience INC.: Research Funding; Takeda Pharmaceutical Company Limited: Speakers Bureau. Kizaki: Nippon Shinyaku,: Research Funding, Speakers Bureau; Celgene: Research Funding, Speakers Bureau; Bristol-Myers Squibb: Research Funding, Speakers Bureau; Novartis: Speakers Bureau.

Source: Blood - November 21, 2018 Category: Hematology Authors: Tokuhira, M., Kimura, Y., Tanaka, Y., Takahashi, Y., Tomikawa, T., Watanabe, J., Anan-Nemoto, T., Sagawa, M., Momose, S., Higashi, M., Takayuki, T., Nakaseko, R., Tamaru, J.-i., Kizaki, M. Tags: 622. Lymphoma Biology-Non-Genetic Studies: Poster I Source Type: research